Clinical trial · Interventional
Acupoint Stimulation for Pain Reduction and the Associated Benefits in Head and Neck Cancer Patients Receiving Concurrent Chemoradiotherapy
Acupoint Stimulation for Pain Reduction
NCT03640195CI-TRIAL-00034486completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study was designed to investigate the effect of Acupoint stimulation on pain reduction, and fatigue, anxiety and depression and quality of life in Head neck cancer receiving Concurrent Chemoradiotherapy.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Head and Neck Cancer | Malignant Head and Neck Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Device: Transcutaneous acupoint electrical stimulation and seeds for auricular acupressure | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Experimental group
- description
- Transcutaneous nerve electrical stimulation and Auricular acupressure.
- interventionNames
- Other: Device: Transcutaneous acupoint electrical stimulation and seeds for auricular acupressure
- type
- NO_INTERVENTION
- label
- Control group
- description
- without intervention
Primary outcomes (1)
- measure
- Difference between the two groups from Baseline in Pain Scores on the Visual Analog Scale at 6 Weeks
- timeFrame
- from enrollment to end of treatment at 6 weeks
- description
- Pain intensity was assessed using visual analogue scales (VAS) , which is a 10-cm continuous line to assess the subjective perception of pain in the case, with a score of 0 on the leftmost end of the line indicating "painless" and 10 points indicating The "most severe pain" and the reliability of pain assessment , and all participants received this linear tool measurement, recording a total of five
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Clinical diagnosis of head and neck cancer with initial concurrent chemoradiotherapy * Must be able to communicate clearly * Must be above age 20 Exclusion Criteria: * Previous radiotherapy * History of arrhythmia or use of a pacemaker * Local swelling or infection over the acupoint area
References
Publications (1)
- DERIVEDChou YH, Yeh ML, Huang TS, Hsu H. Acupoint stimulation improves pain and quality of life in head and neck cancer patients with chemoradiotherapy: A randomized controlled trial. Asia Pac J Oncol Nurs. 2021 Dec 25;9(1):61-68. doi: 10.1016/j.apjon.2021.11.002. eCollection 2022 Jan. PMID 35528798